| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
N/A |
| Shares
Out: |
26,519,000 |
| Market
Cap: |
19.81(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.55 - $1.72 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile VolitionRx is an epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop blood tests to help diagnose and monitor a range of life-altering diseases including certain cancers and diseases associated with NETosis such as sepsis and COVID-19. Co.'s tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Co. is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
99,000 |
210,422 |
928,911 |
| Total Buy Value |
$0 |
$73,100 |
$210,662 |
$1,588,869 |
| Total People Bought |
0 |
5 |
11 |
12 |
| Total Buy Transactions |
0 |
8 |
21 |
37 |
| Total Shares Sold |
0 |
40,000 |
40,000 |
54,949 |
| Total Sell Value |
$0 |
$33,000 |
$33,000 |
$69,924 |
| Total People Sold |
0 |
1 |
1 |
2 |
| Total Sell Transactions |
0 |
2 |
2 |
3 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Terrell Jason Bradley Md |
Chief Medical Officer |
• – – |
2022-06-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,775 |
2,730 |
|
- |
|
| Terrell Jason Bradley Md |
Chief Medical Officer |
• – – |
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
22,845 |
35,145 |
|
- |
|
| Barnes Phillip |
|
– • – |
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,046 |
4,686 |
|
- |
|
| Micallef Jacob Vincent |
Chief Scientific Officer |
• – – |
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,682 |
125,053 |
|
- |
|
| Reynolds Cameron John |
President and CEO |
• • – |
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
32,270 |
1,192,018 |
|
- |
|
| Colman Alan |
|
– • – |
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,569 |
163,279 |
|
- |
|
| Butera Salvatore Thomas |
CEO - Volition Veterinary |
• – – |
2022-06-16 |
4 |
B |
$2.05 |
$20,500 |
D/D |
10,000 |
155,000 |
0.01 |
- |
|
| Terrell Jason Bradley Md |
Chief Medical Officer |
• – – |
2022-06-06 |
4 |
S |
$2.47 |
$36,924 |
D/D |
(14,949) |
12,300 |
|
- |
|
| Innes Guy Archibald |
|
– • – |
2022-05-16 |
4 |
B |
$2.37 |
$23,700 |
D/D |
10,000 |
1,546,615 |
0.01 |
- |
|
| Butera Salvatore Thomas |
CEO - Volition Veterinary |
• – – |
2022-05-01 |
4 |
D |
$2.79 |
$41,850 |
D/D |
(15,000) |
145,000 |
|
- |
|
| Terrell Jason Bradley Md |
Chief Medical Officer |
• – – |
2022-04-11 |
4 |
S |
$2.75 |
$27,500 |
D/D |
(10,000) |
27,249 |
|
- |
|
| Kway Jasmine |
CEO - Singapore Volition |
• – – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
9,604 |
9,604 |
|
- |
|
| Gaetan Michel |
Chief Operating Officer |
• – – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
13,933 |
15,004 |
|
- |
|
| Barnes Phillip |
|
– • – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,640 |
1,640 |
|
- |
|
| Futcher Edward |
|
– • – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,640 |
39,890 |
|
- |
|
| Hughes Terig |
Chief Financial Officer |
• – – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,759 |
10,759 |
|
- |
|
| Reynolds Cameron John |
President and CEO |
• • – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
17,375 |
1,159,748 |
|
- |
|
| Rootsaert Rodney Gerard |
Secretary |
• – – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,036 |
27,434 |
|
- |
|
| Micallef Jacob Vincent |
Chief Scientific Officer |
• – – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
8,443 |
109,371 |
|
- |
|
| Innes Guy Archibald |
|
– • – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,640 |
1,536,615 |
|
- |
|
| Forterre Gael |
Chief Commerical Officer |
• – – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,165 |
55,665 |
|
- |
|
| Faulkes Martin Charles |
|
– • – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
8,443 |
1,514,386 |
|
- |
|
| Nguyen Kim |
|
– • – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,640 |
19,140 |
|
- |
|
| Colman Alan |
|
– • – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,460 |
158,710 |
|
- |
|
| Terrell Jason Bradley Md |
Chief Medical Officer |
• – – |
2022-04-07 |
4 |
A |
$0.00 |
$0 |
I/I |
955 |
955 |
|
- |
|
305 Records found
|
|
Page 7 of 13 |
|
|
0.02 (2.97%) 
